MetaCap

Xilio Therapeutics (XLO) News

NASDAQ: XLOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.56-0.085 (-1.11%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

XLO news summary

We found 3 recent headlines mentioning Xilio Therapeutics (XLO): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire. For price context, XLO is down 1.11% at $7.56. The most recent story, "Xilio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Pipeline and Business Updates", was published by GlobeNewswire on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Xilio Therapeutics headlines

Compare XLO